Search results
PTC Therapeutics (NASDAQ:PTCT) shareholders are up 17% this past week, but still in the red over the...
Simply Wall St. via Yahoo Finance· 5 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders should be happy to see the share price up 28% in...
PTC Therapeutics' (NASDAQ:PTCT) investors will be pleased with their 21% return over the last five...
Simply Wall St. via Yahoo Finance· 10 months agoIt hasn't been the best quarter for PTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders, since the...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 11 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
Investing in PTC Therapeutics (NASDAQ:PTCT) five years ago would have delivered you a 173% gain
Simply Wall St. via Yahoo Finance· 2 years agoThe worst result, after buying shares in a company (assuming no leverage), would be if you lose all...
Why PTC Therapeutics Soared 15% Higher Today
Motley Fool· 6 months agoA new royalty deal was the fuel that powered biotech PTC Therapeutics (NASDAQ: PTCT) stock to a 15% gain on Thursday. Before market open that day, PTC...
Reata's (RETA) Skyclarys PAS Gets FDA Nod, Stock Rises 7%
Zacks via Yahoo Finance· 10 months agoReata's (RETA) prior approval supplement application to update the drug substance specification for...
Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug
Zacks via Yahoo Finance· 5 months agoDespite providing additional information, the FDA declines to lift the clinical hold on Entrada's...
Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
Zacks via Yahoo Finance· 4 months agoBiogen (BIIB) gets positive CHMP opinion recommending marketing authorization to Skyclarys in the EU...
Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
Zacks via Yahoo Finance· 6 months agoSolid Biosciences (SLDB) gains 28% as the FDA clears SGT-003, a gene therapy candidate, for clinical...
